Adipose tissue and inflammation

International Journal of Clinical Practice

Volumn 65, Issue 9, 2011, Pages 913-917

  McGinty, A ^a   Young, I S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; FATTY ACID; GELATINASE B; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 18; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL HYPERPLASIA; CELL INFILTRATION; HUMAN; HYPERTROPHY; INFLAMMATION; INTRAABDOMINAL FAT; LIPID STORAGE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; SUBCUTANEOUS FAT; UPREGULATION; VITAMIN D DEFICIENCY; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; MALE; OBESITY;

EID: 80051897365     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02757.x     Document Type: Review

References (36)

1. Bays HE,. Adiposopathy is "sick fat" a cardiovascular disease? J Am Coll Cardiol 2011; 57: 2461-73.
2. Weiss, et al,. Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease. Int J Clin Pract 2011; 65: 939-44.
3. Trayhurn P,. Adipocyte Biology. In:, Kopelman PG, Caterson ID, Dietz WH, eds. Clinical Obesity in Adults and Children, 3rd edn. Singapore: Wiley-Blackwell, 2010: 103-14.
4. Cousin B, Munoz O, Andre M, et al., A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13: 305-12. (Pubitemid 29072407)
5. Prunet-Marcassus B, Cousin B, Caton D, André M, Pénicaud L, Casteilla L,. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 2006; 312: 727-36.
6. Yagi K, Kondo D, Okazaki Y, Kano K,. A novel preadipocyte cell line established from mouse adult mature adipocytes. Biochem Biophys Res Commun 2004; 321: 967-74. (Pubitemid 39044403)
7. Jumabay M, Zhang R, Yao Y, Goldhaber JI, Boström KI,. Spontaneously beating cardiomyocytes derived from white mature adipocytes. Cardiovasc Res 2010; 85: 17-27.
8. Chazenbalk G, Bertolotto C, Heneidi S, et al., Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS ONE 2011; 6: e17834.
9. Isakson P, Hammarstedt A, Gustafson B, Smith U,. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009; 58: 1550-7.
10. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE,. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-506. (Pubitemid 32734855)
11. Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, Eriksson JW,. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007; 50: 625-33. (Pubitemid 46215507)
12. Kilpeläinen TO, Zillikens MC, Stančákova A, et al., Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011, doi
13. Rung J, Cauchi S, Albrechtsen A, et al., Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009; 41: 1110-5.
14. Samani NJ, Erdmann J, Hall AS, et al., Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-53. (Pubitemid 47204873)
15. Bourlier V, Bouloumie A,. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab 2009; 35: 251-60.
16. Gutierrez DA, Puglisi MJ, Hasty AH,. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diab Rep 2009; 9: 26-32.
17. Lumeng CN, Deyoung SM, Saltiel AR,. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab. 2007; 292: E166-74. (Pubitemid 46052939)
18. Xie L, Ortega MT, Mora S, Chapes SK,. Interactive changes between macrophages and adipocytes. Clin Vaccine Immunol. 2010; 17: 651-9.
19. Harman-Boehm I, Blüher M, Redel H, et al., Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-7. (Pubitemid 46997129)
20. Ortega Martinez de Victoria E, Xu X, Koska J, et al., Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 2009; 58: 385-93.
21. Balistreri CR, Caruso C, Candore G,. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010; 2010: 802078.
22. Fain JN,. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm. 2010; 2010:513948.
23. Montonen J, Drogan D, Joost HG,. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011; 26: 29-38.
24. Pittas AG, Chung M, Trikalinos T, et al., Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-14.
25. Parikh SJ, Edelman M, Uwaifo GI, et al., The relationship between obesity and serum 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-9. (Pubitemid 38368412)
26. Konradsen S, Ag H, Lindberg F, et al., Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008; 47: 87-91.
27. Wortsman J, Matsuoka LY, Chen TC, et al., Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3. (Pubitemid 30667088)
28. Chiu KC, Chu A, Go VL, Saad MF,. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 2004; 79: 820-5. (Pubitemid 41103882)
29. Liu E, Meigs JB, Pittas AG, et al., Plasma 25-hydroxyvitamin D is associated with markers of insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329-4.
30. Shankar A, Sabanayagam C, Kalidindi S,. Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diabetes Care 2011; 34: 1114-9. Epub 2011 Mar 23.
31. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R,. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258-61. (Pubitemid 36700706)
32. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B,. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-6. (Pubitemid 46556596)
33. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV,. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31: 701-7.
34. Westerink J, Visseren FL,. Pharmacological and non-pharmacological interventions to influence adipose tissue function. Cardiovasc Diabetol 2011; 10: 13.
35. Ryan KE, McCance DR, Powell L, McMahon R, Trimble ER,. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis 2007; 194: e123-30. (Pubitemid 47513101)
36. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA,. The impact of long chain n-3 PUFA supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007; 9: 70-80. (Pubitemid 44921044)